Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) - Dougados, Maxime; Kissel, Karsten; Sheeran, Tom; Tak, Paul P.; Conaghan, Philip G.; Martín Mola, Emilio; Schett, Georg; Amital, Howard; Navarro-Sarabia, Federico; Hou, Antony; Bernasconi, Corrado; Huizinga, T. W. J. (Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2013)
Aus: Annals of the Rheumatic Diseases 72.1 (2013): S. 43-50. <http://ard.bmj.com/content/72/1/43>
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.